Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily Lung Function with Albuterol and Ipratropium in COPD
NCT01691482Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of salbutamol, ipratropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jul 2012; status: completed.
02
Drugs
salbutamolipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01691482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691482.